SCIENTIFIC BACKGROUND

ABCC6

Pseudoxanthoma elasticum (PXE) is a progressive systemic disease affecting the elastic connective tissue of the skin, eyes, cardiovascular, and gastrointestinal systems. It is characterized by deposits in the skin that look like xanthomas and are caused by calcification of the elastic fibers of the connective tissue. They first appear on the sides of the neck and later affect the armpits, elbows, wrists, navel, groin and back of the knees. As the disease progresses, they can become papules and, eventually, larger plaques. Irregular stripes, so-called angioid streaks, appear in the retina. More rarely, vascular stenoses occur due to mineralization of the internal elastic lamina of middle arteries and gastrointestinal bleeding.

 

PXE is inherited in an autosomal recessive manner, with an estimated prevalence of 1:25,000 to 1:100,000. The diagnosis of PXE is made clinically on the basis of skin and eye manifestations and can be confirmed histologically by a biopsy of the affected skin areas.

 

The molecular cause is pathogenic variants in the ABCC6 gene (formerly known as MRP6) on chromosome 16p13.1, which codes for the ATP-binding cassette protein 6 of subfamily C of multi-drug resistance proteins (MRP). At least one altered ABCC6 allele is detectable in almost all patients with PXE, and variants on both alleles can be detected in up to 90%. A 16.4 kb deletion, which covers exons 23-29, is particularly common. It occurs in 30% of alleles in PXE patients in the USA and in 5% of alleles in PXE patients in Europe. The most common point mutation is p.(Arg1141*). Together with the 16.4 kb deletion, it represents 70% of all pathogenic variants.

 

References

Kranenburg et al. 2018, Eur J Med Genet 2018 May 22. pii: S1769 / Moitra et al. 2017, Int J Mol Sci 18, 1488 / Germain DP 2017, Orphanet J Rare Dis 12:85 / Pfendner et al. 2007, J Med Genet 44:621

GENES

ABCC6
How to order

LATEST ARTICLES

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more